Format
Sort by
Items per page

Send to

Choose Destination

Best matches for childhood obesity probiotic:

Childhood obesity: a role for gut microbiota? Sanchez M et al. Int J Environ Res Public Health. (2014)

The infant gut microbiome: evidence for obesity risk and dietary intervention. Koleva PT et al. Nutrients. (2015)

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. Miura K et al. World J Gastroenterol. (2014)

Search results

Items: 1 to 20 of 64

1.

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.

Roychowdhury S, Selvakumar PC, Cresci GAM.

Med Sci (Basel). 2018 Jun 5;6(2). pii: E47. doi: 10.3390/medsci6020047. Review.

2.

Consensus and contentious statements on the use of probiotics in clinical practice: A south east Asian gastro-neuro motility association working team report.

Gwee KA, Lee WW, Ling KL, Ooi CJ, Quak SH, Dan YY, Siah KT, Huang JG, Chua ASB, Hilmi IN, Raja Ali RA, Ong C, Simadibrata M, Abdullah M, Sollano JD, Leelakusolvong S, Gonlachanvit S, Lee YY, Ricaforte-Campos JD, Yin YK, Chong KM, Wong CY.

J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14268. [Epub ahead of print] Review.

PMID:
29697855
3.

Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.

Pekmez CT, Dragsted LO, Brahe LK.

Clin Nutr. 2018 Feb 17. pii: S0261-5614(18)30077-3. doi: 10.1016/j.clnu.2018.02.014. [Epub ahead of print] Review.

PMID:
29496274
4.

Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial.

Jones RB, Alderete TL, Martin AA, Geary BA, Hwang DH, Palmer SL, Goran MI.

Pediatr Obes. 2018 Feb 28. doi: 10.1111/ijpo.12273. [Epub ahead of print]

PMID:
29493105
5.

Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?

Nobili V, Putignani L, Mosca A, Chierico FD, Vernocchi P, Alisi A, Stronati L, Cucchiara S, Toscano M, Drago L.

Arch Med Sci. 2018 Jan;14(1):81-87. doi: 10.5114/aoms.2016.62150. Epub 2016 Sep 6.

6.

Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases.

Plaza-Díaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A.

Nutrients. 2018 Jan 5;10(1). pii: E42. doi: 10.3390/nu10010042. Review.

7.

The importance of the microbiome in pediatrics and pediatric infectious diseases.

Gaufin T, Tobin NH, Aldrovandi GM.

Curr Opin Pediatr. 2018 Feb;30(1):117-124. doi: 10.1097/MOP.0000000000000576.

PMID:
29206649
8.

Microbial Therapeutics Designed for Infant Health.

Watkins C, Stanton C, Ryan CA, Ross RP.

Front Nutr. 2017 Oct 26;4:48. doi: 10.3389/fnut.2017.00048. eCollection 2017. Review.

9.

Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.

Hampe CS, Roth CL.

Endocrine. 2017 Nov;58(2):207-227. doi: 10.1007/s12020-017-1433-z. Epub 2017 Oct 19. Review.

PMID:
29052181
10.
11.

Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease.

Poeta M, Pierri L, Vajro P.

Children (Basel). 2017 Aug 2;4(8). pii: E66. doi: 10.3390/children4080066. Review.

12.

Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease.

Gibson PS, Lang S, Dhawan A, Fitzpatrick E, Blumfield ML, Truby H, Hart KH, Moore JB.

J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):141-149. doi: 10.1097/MPG.0000000000001624. Review.

13.

Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses.

Rondanelli M, Faliva MA, Perna S, Giacosa A, Peroni G, Castellazzi AM.

Gut Microbes. 2017 Nov 2;8(6):521-543. doi: 10.1080/19490976.2017.1345414. Epub 2017 Jul 21.

14.

Metabolic in Vivo Labeling Highlights Differences of Metabolically Active Microbes from the Mucosal Gastrointestinal Microbiome between High-Fat and Normal Chow Diet.

Oberbach A, Haange SB, Schlichting N, Heinrich M, Lehmann S, Till H, Hugenholtz F, Kullnick Y, Smidt H, Frank K, Seifert J, Jehmlich N, von Bergen M.

J Proteome Res. 2017 Apr 7;16(4):1593-1604. doi: 10.1021/acs.jproteome.6b00973. Epub 2017 Mar 21.

PMID:
28252966
15.

Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents.

Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R.

J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):413-417. doi: 10.1097/MPG.0000000000001422.

PMID:
28230607
16.

Nutrition and skin: Kids are not just little people.

McCusker M, Sidbury R.

Clin Dermatol. 2016 Nov - Dec;34(6):698-709. doi: 10.1016/j.clindermatol.2016.07.004. Epub 2016 Jul 9. Review.

PMID:
27968929
17.

Gut Microbiota and Obesity.

Valsecchi C, Carlotta Tagliacarne S, Castellazzi A.

J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S157-S158.

PMID:
27741163
18.

Transitioning From Descriptive to Mechanistic Understanding of the Microbiome: The Need for a Prospective Longitudinal Approach to Predicting Disease.

Martin VJ, Leonard MM, Fiechtner L, Fasano A.

J Pediatr. 2016 Dec;179:240-248. doi: 10.1016/j.jpeds.2016.08.049. Epub 2016 Sep 12. No abstract available.

19.

Growth of infants consuming whey-predominant term infant formulas with a protein content of 1.8 g/100 kcal: a multicenter pooled analysis of individual participant data.

Alexander DD, Yan J, Bylsma LC, Northington RS, Grathwohl D, Steenhout P, Erdmann P, Spivey-Krobath E, Haschke F.

Am J Clin Nutr. 2016 Oct;104(4):1083-1092. Epub 2016 Sep 7.

PMID:
27604774
20.

Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.

Caffarelli C, Santamaria F, Di Mauro D, Mastrorilli C, Mirra V, Bernasconi S.

Ital J Pediatr. 2016 Aug 27;42(1):75. doi: 10.1186/s13052-016-0288-x. Review.

Supplemental Content

Loading ...
Support Center